Theological Support of Stem Cell Research

Pope John Paul II has stated that support of embryonic stem cell research evidences moral corruption. Opponents of embryonic stem cell research have cast the debate surrounding this research as nothing but the next chapter in the abortion controversy. The ethical issues involved with this research, however, are far too complex to be reduced to such a simple assessment. Portraying the stem cell debate as the abortion controversy is at best intellectually misleading, at worst ethically negligent.

Written byTed Peters
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The stem cell debate has been framed by the wrong basic question: its moral heart lies not with abortion, but in its potential good. Stem cell research is morally significant first because it promises healing. Implanted stem cells, it appears, teach the body to heal itself, rejuvenating failing tissues, from organs to nerves. These therapies promise to ease the suffering of millions inflicted with such debilitating diseases as Parkinson's, heart and liver failure, juvenile diabetes, Alzheimer's, and cancer.

It is our considered judgment that not only is this research morally permissible, there is an ethical and theological mandate to actively support it. To not support stem cell research, we have concluded, is unethical.

The principal grounding of our support is beneficence, a bioethical variant of the Christian understanding of agape love. Theological and ethical reflection are at their best when framed by beneficence--a selfless love of one's neighbor that inspires ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies